相关实验视频

Updated: Jun 17, 2025

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

核磁共振成像放射学数据分析,以区分恶性混合穆勒瘤和子宫内膜癌

Mayur Virarkar¹, Taher Daoud², Jia Sun²

¹Department of Radiology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA.

|August 10, 2024

概括

放射学和灰度共发生矩阵 (GLCM) 的特征可以帮助区分子宫内膜癌 (EC) 和恶性混合Müllerian瘤 (MMMTs). 特定的纹理特征也可以预测这些妇科癌症的整体存活率 (OS).

科学领域:

妇科瘤学妇科瘤学
放射学放射学是一门学科.
医学成像分析医学成像分析

背景情况:

恶性混合Müllerian瘤 (MMMTs) 和子宫内膜癌 (EC) 是不同的妇科恶性瘤.
区分MMMT和EC可能具有挑战性,影响治疗策略和患者的治疗结果.
定量成像特征,如放射学,为改善瘤特征提供了潜力.

研究的目的:

为了比较MMMTs和EC之间的定量放射学数据.
识别与整体存活率 (OS) 相关的纹理特征.
评估放射学在区分EC和MMMTs方面的实用性.

主要方法:

对61名患者 (36名EC,25名MMMTs) 的回顾性分析.
取和分析放射性和灰度共发生矩阵 (GLCM) 的特征.
使用威尔科克森等级和费舍尔精确测试的统计比较.
用弹性网进行特征选择的后勤回归和用于生存分析的考克斯回归.

主要成果:

在EC和MMMT之间,形和瘤体积显著不同 (p ≤0.05).
集群阴影范围,集群阴影的角度方差和平方方差的总和范围预测了EC状态 (p ≤ 0.05).
"256角能量变量"纹理特征独立预测了OS (p = 0.004).

结论:

瘤体积和特定的纹理特征可以帮助区分EC和MMMT.
放射性分析,特别是纹理特征,在预测患者结果 (OS) 中表现有希望.
定量成像指标可以提高妇科癌症的诊断准确性和预后评估.

关键词:

人工智能的人工智能是人工智能.这是子宫内膜癌的癌症.机器学习是机器学习.混合的Müllerian瘤是一个混合的瘤.无线电学 (radiomics) 是一种无线电学.

更多相关视频

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...